TickerFacts.

Advanced Biomed Inc. (ADVB): Shareholders' Equity

Annual figures by period end, from SEC filings.

$12.28M
As of 2026-06-30
2024-06-30: $1.66M2025-06-30: $3.48M2026-06-30: $12.28M$12.28M
2024-06-30 Shareholders' Equity (USD) 2026-06-30
Period endedShareholders' EquityChange YoYSource filing
2026-06-30$12.28M+253.0%2026-10-13, Balance as of period end
2025-06-30$3.48M+109.1%2026-10-13, Balance as of period end
2024-06-30$1.66Mn/a2025-10-08, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Advanced Biomed Inc. (ADVB)2026-06-30$12.28M+253.0%
YD Bio Ltd (YDES)2025-12-31-$2.86Mn/m
Aclarion, Inc. (ACON)2025-12-31$12.84Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31$8.61M+3.5%
CapForce Inc. (CFOR)2025-12-31$31.86M+331.6%
First Choice Healthcare Solutions, Inc. (FCHS)2025-12-31-$39.53Mn/m
American Shared Hospital Services (AMS)2025-12-31$27.69M-7.8%
Exagen Inc. (XGN)2025-12-31$17.45M+82.9%
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m

Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗